These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11594582)

  • 21. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
    Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
    J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand.
    Braun FK; Al-Yacoub N; Plötz M; Möbs M; Sterry W; Eberle J
    J Invest Dermatol; 2012 Feb; 132(2):429-39. PubMed ID: 22011910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death.
    Wu J; Salva KA; Wood GS
    J Invest Dermatol; 2015 Mar; 135(3):861-868. PubMed ID: 25140833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.
    Yumeen S; Girardi M
    Yale J Biol Med; 2020 Mar; 93(1):111-121. PubMed ID: 32226341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetics of Cutaneous T-Cell Lymphomas.
    Hara N; Sawada Y
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syringotropic cutaneous T cell lymphoma treated with PUVA therapy.
    Venturini A; Zane C; Rodella R; Leali C; Calzavara Pinton P; Zorzi F
    Eur J Dermatol; 2005; 15(4):262-4. PubMed ID: 16048754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Denileukin diftitox.
    Saxon M
    Clin J Oncol Nurs; 2000; 4(6):289, 293. PubMed ID: 11899329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression.
    Borcherding N; Voigt AP; Liu V; Link BK; Zhang W; Jabbari A
    Clin Cancer Res; 2019 May; 25(10):2996-3005. PubMed ID: 30718356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
    Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
    Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma.
    Wu J; Wood GS
    Arch Dermatol; 2011 Apr; 147(4):443-9. PubMed ID: 21173302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentoxifylline induces apoptosis in vitro in cutaneous T cell lymphoma (HuT-78) and enhances FasL mediated killing by upregulating Fas expression.
    Rishi L; Gahlot S; Kathania M; Majumdar S
    Biochem Pharmacol; 2009 Jan; 77(1):30-45. PubMed ID: 18851957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Forodesine in the treatment of cutaneous T-cell lymphoma.
    Lewis DJ; Duvic M
    Expert Opin Investig Drugs; 2017 Jun; 26(6):771-775. PubMed ID: 28447489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.
    Xu J; Huang H; Wang S; Chen Y; Yin X; Zhang X; Zhang Y
    Arch Dermatol Res; 2020 Sep; 312(7):513-525. PubMed ID: 31676945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New drugs in cutaneous T-cell lymphomas.
    Scarisbrick JJ
    Curr Opin Oncol; 2016 Sep; 28(5):384-9. PubMed ID: 27390044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous T cell lymphoma: update on treatment.
    Wollina U
    Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma.
    Wei T; Biskup E; Gjerdrum LM; Niazi O; Ødum N; Gniadecki R
    Oncotarget; 2016 Jul; 7(30):48391-48400. PubMed ID: 27351221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures.
    Herrera A; Cheng A; Mimitou EP; Seffens A; George D; Bar-Natan M; Heguy A; Ruggles KV; Scher JU; Hymes K; Latkowski JA; Ødum N; Kadin ME; Ouyang Z; Geskin LJ; Smibert P; Buus TB; Koralov SB
    Blood; 2021 Oct; 138(16):1456-1464. PubMed ID: 34232982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
    Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
    Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.